US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

142.65

-7.3600-4.91%

Volume:596.43K

Turnover:88.54M

Market Cap:459.97M

PE:- -

High:154.44

Open:148.66

Low:141.59

Close:150.01

52wk High:198.18

52wk Low:32.55

Shares:3.22M

Float Shares:3.22M

Volume Ratio:1.07

T/O Rate:18.50%

Dividend:1.34

Dividend Rate:0.94%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sector Update: Health Care Stocks Mixed Premarket Tuesday

MT Newswires Live

FDA issues Aldeyra CRL saying reproxalap NDA failed to demonstrate efficacy

How Did the FDA Shatter Investor Confidence In Aldeyra Therapeutics Stock (ALDX) Today?

FDA Issues Second Complete Response Letter for Reproxalap

Analysts Conflicted on These Healthcare Names: Cochlear (OtherCHEOF), Universal Health (UHS) and Vera Therapeutics (VERA)

Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026

Press Release: IceCure Reports 2025 Full Year Financial & Operational Results

Incannex regains compliance with Nasdaq minimum bid price rule

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), DocGo (DCGO) and Editas Medicine (EDIT)

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Voyager Therapeutics (VYGR) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields

Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM) and Merck & Company (MRK)

Peijia Medical Wins First U.S. FDA Clearance for DCwire Micro Guidewire

Wardwizard Healthcare CFO Resigns; Shares Jump 5%

MT Newswires Live

BioCardia Advances Helix Catheter Toward FDA Marketing Clearance

Peijia Medical-B Achieves FDA 510(k) Clearance for DCwire® Micro Guidewire

Advancing Pipeline and 2026 Clinical Catalysts Underpin Buy Rating on Kyntra Bio

Nvidia Expands Open Model Families to Support New Agentic, Physical, Healthcare AI

MT Newswires Live

Predict taps Mistral chief Cafagna to drive Digital Healthcare growth

Healthcare & Medical Investment Corp. Posts Modest Growth and Signals Flat Outlook

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LABU/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":142.65,"timestamp":1774033373244,"preClose":150.01,"halted":0,"volume":596430,"delay":0,"changeRate":-0.049063395773614994,"floatShares":3224486,"shares":3224486,"eps":0,"marketStatus":"Trading","change":-7.36,"latestTime":"03-20 15:03:02 EDT","open":148.66,"high":154.44,"low":141.59,"amount":88535047.3452,"amplitude":0.085661,"askPrice":142.83,"askSize":20,"bidPrice":142.58,"bidSize":100,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774036800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":150.01,"sharesOutstanding":3074486,"nav":145.807,"aum":470151875.04,"dividendRate":0.009359,"bidAskSpread":0.002107,"preHourTrading":{"tag":"盘前","latestPrice":149.08,"preClose":150.01,"latestTime":"09:29 EDT","volume":2670,"amount":395890.9659,"timestamp":1774013390002,"change":-0.93,"changeRate":-0.0062,"amplitude":0.028865},"postHourTrading":{"tag":"盘后","latestPrice":150.8,"preClose":150.01,"latestTime":"19:59 EDT","volume":6614,"amount":993072.7812,"timestamp":1773964771547,"change":0.79,"changeRate":0.005266,"amplitude":0.008733},"volumeRatio":1.070237,"impliedVol":1.0047,"impliedVolPercentile":0.8048},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":3224486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.070237,"shares":3224486,"dividePrice":1.3351,"high":154.44,"amplitude":0.085661,"preClose":150.01,"low":141.59,"week52Low":32.55,"pbRate":"--","week52High":198.18,"institutionHeld":0,"latestPrice":142.65,"committee":0.666667,"eps":0,"divideRate":0.009359,"volume":596430,"delay":0,"ttmEps":0,"open":148.66,"prevYearClose":159.39,"prevWeekClose":148.85,"prevMonthClose":172.7,"prevQuarterClose":159.39,"fiveDayClose":148.85,"twentyDayClose":163.19,"sixtyDayClose":176.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620420382","title":"Sector Update: Health Care Stocks Mixed Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2620420382","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620420382?lang=en_us&edition=fundamental","pubTime":"2026-03-17 21:16","pubTimestamp":1773753404,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF  down 0.1% and the iShares Biotechnology ETF  0.4% higher.Eupraxia Pharmaceuticals  shares were up more than 1% after the company said data from its ongoing trial evaluating EP-104GI for eosinophilic esophagitis treatment showed 59% of patients achieved clinical remission at 12 weeks.Monte Rosa Therapeutics  stock was down 1% after the company reported that it swung to a Q4 net loss as collaboration revenue declined during the period.Lensar  shares were down more than 24% after the company said it has reached an agreement with Alcon  to terminate their planned merger.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","IBB","LNSR","LU1804176565.USD","BK4581","BK7094","GLUE","BK4139","EPRX","ALC","XLV","BK4082","BK4539","ALC.AU","LU2265009873.SGD","BK4585","BK4534","XBI","BK4198","LABU"],"gpt_icon":0},{"id":"2620695420","title":"FDA issues Aldeyra CRL saying reproxalap NDA failed to demonstrate efficacy","url":"https://stock-news.laohu8.com/highlight/detail?id=2620695420","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620695420?lang=en_us&edition=fundamental","pubTime":"2026-03-17 21:11","pubTimestamp":1773753069,"startTime":"0","endTime":"0","summary":"Aldeyra (ALDX) announced receipt of a complete response letter, or CRL, from the FDA for the new drug application, or NDA, of reproxalap, an invest...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-issues-aldeyra-crl-saying-reproxalap-nda-failed-to-demonstrate-efficacy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-issues-aldeyra-crl-saying-reproxalap-nda-failed-to-demonstrate-efficacy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRL","BK4585","LU0128526141.USD","LU0390134368.USD","BK4121","LU1815336091.USD","LU0029874061.USD","BK4588","LU0757428866.USD","BK4530","IE00BFMHRM44.USD","LABU","ALDX","BK4139"],"gpt_icon":0},{"id":"2620203004","title":"How Did the FDA Shatter Investor Confidence In Aldeyra Therapeutics Stock (ALDX) Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620203004","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620203004?lang=en_us&edition=fundamental","pubTime":"2026-03-17 21:10","pubTimestamp":1773753025,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics stock fell hard on Tuesday after it received a CRL from the FDA.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/how-the-fda-shattered-investor-confidence-in-aldeyra-therapeutics-stock-aldx-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/how-the-fda-shattered-investor-confidence-in-aldeyra-therapeutics-stock-aldx-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALDX","BK4588","BK4139","LABU","BK4585"],"gpt_icon":0},{"id":"2620342755","title":"FDA Issues Second Complete Response Letter for Reproxalap","url":"https://stock-news.laohu8.com/highlight/detail?id=2620342755","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620342755?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:58","pubTimestamp":1773752309,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics ( ($ALDX) ) has shared an update. On March 17, 2026, Aldeyra Therapeutics announced that the U.S. Food and Drug Administration...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fda-issues-second-complete-response-letter-for-reproxalap?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fda-issues-second-complete-response-letter-for-reproxalap?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","LABU"],"gpt_icon":0},{"id":"2620342250","title":"Analysts Conflicted on These Healthcare Names: Cochlear (OtherCHEOF), Universal Health (UHS) and Vera Therapeutics (VERA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620342250","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620342250?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:30","pubTimestamp":1773750629,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cochlear (CHEOF – Research Report), Universal Heal...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-cochlear-othercheof-universal-health-uhs-and-vera-therapeutics-vera-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-cochlear-othercheof-universal-health-uhs-and-vera-therapeutics-vera-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","BK4137","BK4585","LU0029874061.USD","LU0128526141.USD","BK4139","XLV","UHS","BK4539","BK4588","XBI","LABU","HCSG","LU2324357040.USD","VERA","BK4581"],"gpt_icon":0},{"id":"2620427689","title":"Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620427689","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620427689?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:30","pubTimestamp":1773750600,"startTime":"0","endTime":"0","summary":"SEATTLE and VANCOUVER, British Columbia, March  17, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/17/3257199/0/en/Achieve-Life-Sciences-to-Announce-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Host-Conference-Call-and-Webcast-on-March-24-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HST","BK4181","BK4218","LABU","BK4585","BK4588"],"gpt_icon":0},{"id":"2620228724","title":"Press Release: IceCure Reports 2025 Full Year Financial & Operational Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620228724","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620228724?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:30","pubTimestamp":1773750600,"startTime":"0","endTime":"0","summary":"Record 4 quarter and full year sales of $1.3 million and $3.4 million, respectively. Strong commercial momentum for ProSense in the U.S. and globally following FDA clearance in low-risk breast cancer and medical society recommendations. 30 hybrid commercial-clinical sites to be added for FDA approved post-marketing study in addition to growing pipeline of potential commercial customers. IceCure Applies to Expand Regulatory Approval in Canada for ProSense Cryoablation to Include the Treatment of Low-Risk Breast Cancer. Conference call to be held today at 11:00 am Eastern Time. CAESAREA, Israel, March 17, 2026 /PRNewswire/ -- IceCure Medical Ltd.  , developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today reported record sales as of and for the twelve months ended December 31, 2025 as well as recent commercial and clinical updates.Three significant events are expected to drive commercial adoption of ProSense:. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4022","ICCM","BK4588","R","BK4232","BK4082","LABU"],"gpt_icon":0},{"id":"2620424164","title":"Incannex regains compliance with Nasdaq minimum bid price rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2620424164","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620424164?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:16","pubTimestamp":1773749764,"startTime":"0","endTime":"0","summary":"Incannex (IXHL) Healthcare has regained compliance with the Nasdaq minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The Company ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/incannex-regains-compliance-with-nasdaq-minimum-bid-price-rule-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/incannex-regains-compliance-with-nasdaq-minimum-bid-price-rule-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","BK4585","XBI","BK4007","IXHL","BK4581","LABU","NQmain"],"gpt_icon":0},{"id":"2620842123","title":"Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), DocGo (DCGO) and Editas Medicine (EDIT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620842123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620842123?lang=en_us&edition=fundamental","pubTime":"2026-03-17 19:50","pubTimestamp":1773748226,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Perspective Therapeutics (CATX – Research Report), DocGo (DCGO – ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-perspective-therapeutics-catx-docgo-dcgo-and-editas-medicine-edit-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-perspective-therapeutics-catx-docgo-dcgo-and-editas-medicine-edit-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0029874061.USD","XLV","BK4585","HCSG","XBI","BK4588","BK4196","CATX","DCGO","EDIT","BK4556","LU0128526141.USD","BK4581","LABU","BK4139"],"gpt_icon":0},{"id":"2620712429","title":"Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Voyager Therapeutics (VYGR) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620712429","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620712429?lang=en_us&edition=fundamental","pubTime":"2026-03-17 19:30","pubTimestamp":1773747015,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Merit Medical Systems (MMSI – Research Report), Voya...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merit-medical-systems-mmsi-voyager-therapeutics-vygr-and-structure-therapeutics-inc-sponsored-adr-gpcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merit-medical-systems-mmsi-voyager-therapeutics-vygr-and-structure-therapeutics-inc-sponsored-adr-gpcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","MMSI","BK4585","BK4581","LU1559883803.SGD","GPCR","VYGR","BK4588","LU0128526141.USD","BK4139","HCSG","BK4007","BK4599","XBI","XLV","LU0566484027.USD","LABU","LU0029874061.USD","BK4198"],"gpt_icon":0},{"id":"2620421785","title":"Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields","url":"https://stock-news.laohu8.com/highlight/detail?id=2620421785","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620421785?lang=en_us&edition=fundamental","pubTime":"2026-03-17 19:27","pubTimestamp":1773746820,"startTime":"0","endTime":"0","summary":"Investors often turn to dividend-yielding stocks in times of market turbulence. Benzinga provides accurate analyst ratings for top healthcare stocks.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/17/Merck-Logo--Sign-At-Merck-Research-Labor.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/17/Merck-Logo--Sign-At-Merck-Research-Labor.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/dividends/26/03/51291756/wall-streets-most-accurate-analysts-give-their-take-on-3-health-care-stocks-with-over-3-dividend-yields-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/dividends/26/03/51291756/wall-streets-most-accurate-analysts-give-their-take-on-3-health-care-stocks-with-over-3-dividend-yields-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4588","XLV","BK4585","XBI","BK4581","LABU"],"gpt_icon":0},{"id":"2620293394","title":"Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM) and Merck & Company (MRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620293394","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620293394?lang=en_us&edition=fundamental","pubTime":"2026-03-17 19:10","pubTimestamp":1773745837,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Rhythm Pharmaceuticals (RYTM – Research Report) an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rhythm-pharmaceuticals-rytm-and-merck-company-mrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rhythm-pharmaceuticals-rytm-and-merck-company-mrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1430594728.SGD","BK4516","LU2361044949.HKD","LU0265550359.USD","LU1069347547.HKD","MRK","LU0070302665.USD","SG9999014575.USD","LU1989771016.USD","LU1037948541.HKD","LU0965509101.SGD","IE00BLSP4452.SGD","BK4585","LU1093756168.USD","LU1934455277.USD","LU2023250843.SGD","LU0029874061.USD","LU0106261372.USD","LU1917777945.USD","LU0234572021.USD","SG9999001176.SGD","LU0130102774.USD","LU1035773651.USD","LU1066053197.SGD","LU0238689110.USD","SG9999015341.SGD","SG9999014559.SGD","LU1974910355.USD","LU0128526141.USD","IE00BLSP4239.USD","IE00BN8TJ469.HKD","LU1989772840.SGD","LU1037948897.HKD","LU1201861249.SGD","LU1571399168.USD","XBI","IE00B2B36J28.USD","LU2023250504.SGD","IE000M9KFDE8.USD","LU1934455194.USD","IE00BJT1NW94.SGD","BK4137","IE0009355771.USD","LU0965509283.SGD","LU1929549753.HKD","LU2089984988.USD","LU1066051811.HKD","IE0002141913.USD","LU1934455863.HKD","RYTM","SG9999002224.SGD","LU0320765646.SGD","LU0868494617.USD","LU2361044865.SGD","SG9999013999.USD","LU0006306889.USD","IE00BFTCPJ56.SGD","BK4588","LABU","LU1066051498.USD","IE00BSNM7G36.USD","LU2360032135.SGD","BK4534","LU0942090050.USD","SG9999001440.SGD","LU2106854487.HKD","LU2125154778.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU0980610538.SGD","LU0985320562.USD","LU2125154935.USD","LU2468319806.SGD","LU0208291251.USD","BK4581","LU0648001328.SGD","LU1023059063.AUD","LU0868494708.USD","LU1116320901.HKD","IE00BBT3K403.USD","LU1057294990.SGD","LU2324357040.USD","LU0203345920.USD","LU0965508806.USD","LU1983299246.USD","LU2461242641.AUD","IE00B1BXHZ80.USD","LU1061106388.HKD","LU0098860793.USD","LU0289739699.SGD","LU0432979614.USD","LU2112291526.USD","LU0265550946.USD","SG9999001176.USD","SG9999014542.SGD","SG9999015358.SGD","LU0965509010.AUD","LU0130517989.USD","BK4139","LU0266013472.USD","LU1941712264.USD","IE00B4R5TH58.HKD","LU2361045086.USD","SG9999002232.USD","SG9999014567.USD","BK4559","LU1093756325.SGD","SGXZ57979304.SGD","BK4007","LU0477156953.USD","LU0320765489.SGD","BK4533","LU0122379950.USD","LU1941712348.USD","LU0203347892.USD","LU1989772923.USD","LU1291159041.SGD","LU0861579265.USD","LU1066051225.USD","LU1585245621.USD","LU1699723380.USD","LU1116320737.USD","BK4550","LU0211331839.USD","LU1162221912.USD"],"gpt_icon":0},{"id":"2620426667","title":"Peijia Medical Wins First U.S. FDA Clearance for DCwire Micro Guidewire","url":"https://stock-news.laohu8.com/highlight/detail?id=2620426667","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620426667?lang=en_us&edition=fundamental","pubTime":"2026-03-17 18:47","pubTimestamp":1773744434,"startTime":"0","endTime":"0","summary":"An announcement from Peijia Medical Ltd. ( ($HK:9996) ) is now available. Peijia Medical Limited announced that its subsidiary Achieva Medical Limi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/peijia-medical-wins-first-u-s-fda-clearance-for-dcwire-micro-guidewire?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/peijia-medical-wins-first-u-s-fda-clearance-for-dcwire-micro-guidewire?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588","GWRE","LU0963586101.USD","BK4023"],"gpt_icon":0},{"id":"2620425425","title":"Wardwizard Healthcare CFO Resigns; Shares Jump 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620425425","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620425425?lang=en_us&edition=fundamental","pubTime":"2026-03-17 18:45","pubTimestamp":1773744322,"startTime":"0","endTime":"0","summary":"Wardwizard Healthcare Ltd (BOM:512063) said Chief Financial Officer Mittalben Patel will step down from the role, effective March 30, to pursue other professional opportunities, according to a Monday filing on Indian bourses.Shares of the company jumped 5% in Tuesday's trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","LU0029874061.USD","XLV","BK4585","HCSG","XBI","BK4588","LU0128526141.USD","BK4581","LABU"],"gpt_icon":0},{"id":"2620425631","title":"BioCardia Advances Helix Catheter Toward FDA Marketing Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2620425631","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620425631?lang=en_us&edition=fundamental","pubTime":"2026-03-17 18:32","pubTimestamp":1773743550,"startTime":"0","endTime":"0","summary":"BioCardia ( ($BCDA) ) has provided an announcement. On March 17, 2026, BioCardia announced that the U.S. Food and Drug Administration accepted its ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biocardia-advances-helix-catheter-toward-fda-marketing-clearance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biocardia-advances-helix-catheter-toward-fda-marketing-clearance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BCDA","LABU","BK4588","BK4139"],"gpt_icon":0},{"id":"1152930273","title":"Peijia Medical-B Achieves FDA 510(k) Clearance for DCwire® Micro Guidewire","url":"https://stock-news.laohu8.com/highlight/detail?id=1152930273","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152930273?lang=en_us&edition=fundamental","pubTime":"2026-03-17 18:18","pubTimestamp":1773742695,"startTime":"0","endTime":"0","summary":"Peijia Medical-B (09996) has announced that its DCwire® micro guidewire, independently designed and developed by its subsidiary Jiaqi Biological Co., Ltd., has recently received 510(k) clearance from...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1574","LABU","159891","BK4588","BK4585","BK1583","09996"],"gpt_icon":0},{"id":"2620423172","title":"Advancing Pipeline and 2026 Clinical Catalysts Underpin Buy Rating on Kyntra Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2620423172","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620423172?lang=en_us&edition=fundamental","pubTime":"2026-03-17 18:16","pubTimestamp":1773742613,"startTime":"0","endTime":"0","summary":"Kyntra Bio, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Matthew Keller from H.C. Wainwright reiterated a B...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/advancing-pipeline-and-2026-clinical-catalysts-underpin-buy-rating-on-kyntra-bio-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/advancing-pipeline-and-2026-clinical-catalysts-underpin-buy-rating-on-kyntra-bio-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","BK4588","LABU","XBI","XLV"],"gpt_icon":0},{"id":"2620440151","title":"Nvidia Expands Open Model Families to Support New Agentic, Physical, Healthcare AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2620440151","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620440151?lang=en_us&edition=fundamental","pubTime":"2026-03-17 17:22","pubTimestamp":1773739342,"startTime":"0","endTime":"0","summary":"Nvidia  said late Monday it is expanding its open model families to support new agentic, physical and healthcare artificial intelligence usage.The expanded portfolio includes Nemotron for agentic systems, Cosmos for physical AI, Alpamayo for autonomous vehicles, Isaac GR00T for robotics, and BioNeMo for biomedical research.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"07fde4bd3abdfcae1ed337fb0cbfa4c5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2236285917.USD","HK0000306685.HKD","LU0528227936.USD","SGXZ51526630.SGD","SG9999017495.SGD","LU1674673428.USD","LU2083900584.USD","LU2602419157.SGD","LU0823421416.USD","LU1923622291.USD","LU2168564495.EUR","LU0061475181.USD","LU0128525929.USD","SNVD.UK","NVD3.UK","LU1992135472.HKD","BK4551","BK4588","3NVD.UK","LU0823434583.USD","LU0985320562.USD","LU0689626769.HKD","IE00BMPRXN33.USD","LU2360107168.USD","LU0097036916.USD","LU1323610961.USD","SG9999018857.SGD","LU1868836757.USD","LU0353189680.USD","LU0965509101.SGD","LU2023251221.USD","LU1037948897.HKD","LU0310799852.SGD","LU1778281490.HKD","LU1127390331.HKD","LU0719512351.SGD","LU0048584097.USD","BK4527","NVIW.SI","IE00BKVL7J92.USD","LU1267930730.SGD","LU2250418816.HKD","LU2931357623.SGD","LU0708995401.HKD","LU1935042215.USD","LU2361044949.HKD","SG9999014906.USD","LU1989764664.SGD","LU2505996681.GBP","IE0009356076.USD","BK4587","LU0820561818.USD","LU2063271972.USD","LU2756315664.SGD","LU1691799644.USD","LU0345768740.USD","LU0154236417.USD","IE000W1ABFV2.USD","LU1989764748.USD","LU1923622614.USD","BK4532","LU2028103732.USD","NVD2.UK","SG9999014880.SGD","LU0354030438.USD","LU0266013472.USD","LU0211328371.USD","LU0943347566.SGD","IE0009G5SDU7.USD","LU2452424414.USD","IE0004445015.USD","LU2065171402.SGD","NVDY","LU1670756490.USD","LU0642271901.SGD","LU0390134368.USD","LU1623119135.USD","LU2125909247.SGD","BK4598","HK0000320264.USD","LU2247934214.USD","LU0096362180.USD","LU0823434740.USD","LU2092627202.USD","LU1316542783.SGD","LU0109391861.USD","LU2237957902.USD","LU2552382215.SGD","LU0210533765.USD","LU2286300806.USD","IE00BMPRXR70.SGD","LU0265550359.USD","LU0256863811.USD","SG9999001424.SGD","LU0672654240.SGD","LU2461242641.AUD","LU1366333091.USD","IE00B3S45H60.SGD","IE00BYXW3230.USD","LU1244550577.SGD","LU1917777945.USD","LU2361045086.USD","SG9999014898.SGD","LU0187121727.USD","LU0417517546.SGD","NVDS","LU2244417387.USD","LU1839511570.USD","IE00BDRTCR15.USD","LU0444973449.USD","IE0004086264.USD","LU1951200564.SGD","LU1934455277.USD","LU1988902786.USD","LU2111349929.HKD","LU0225283273.USD","LU0029864427.USD","BK4554","LU0211327993.USD","LU0203201768.USD","SG9999002232.USD","LU2471134796.USD","NVDB","IE00B3M56506.USD","LU1202635105.USD","LU0557290698.USD","LU2272731865.HKD","IE00BQXX3C00.GBP","IE00BKDWB100.SGD","LU0787776722.HKD","LU2322448791.USD","LU1712237335.SGD","IE00BK4W5L77.USD","LU0354030511.USD","LU0476273544.USD","LU0786609619.USD","IE0001KFT4U8.USD","BK4549","LU1718418525.SGD","IE00BQXX3F31.USD","LU1852331112.SGD","LU0868494617.USD","BK4141","LU1868837136.USD","LU2089985449.USD","LU1232071149.USD","BK4581","LU1242518931.SGD","LU1261432733.SGD","LU0251132253.USD","LU2413666699.HKD","LU0006306889.USD","LU1861220033.SGD","LU1119994496.HKD","IE00B1XK9C88.USD","LU0274383776.USD","HK0000914686.HKD","LU0061474705.USD","IE00BWXC8680.SGD","LU2413666426.HKD","LU2463028550.USD","IE0034235188.USD","IE00BKPKM429.USD","LU2360032135.SGD","LU2491050071.SGD","IE0034235303.USD","LU2097344357.USD","LU2023250504.SGD","LU1116320901.HKD","LU1804176565.USD","IE00BZ1G4Q59.USD","LU1435385759.SGD","LU0106261372.USD","LU1496350171.SGD","LU0861579265.USD","LU2322448957.HKD","LU1366192091.USD","LU2108987350.USD","LU2265009873.SGD","IE00B19Z9505.USD","LU1989772840.SGD","LU1720051017.SGD","LU2357125470.USD","LU0308772762.SGD","LU1571399168.USD","LU1861215975.USD","IE000ITXATA3.USD","IE00BN29S564.USD","BK4548","IE000KEQY171.SGD","LU2264538146.SGD","IE00BMPRXQ63.HKD","LU1868836591.USD","LU1548497426.USD","LU2168564149.EUR","LU2097344431.USD","LU2125909593.SGD","NVD","LU1868836914.USD","LU0082616367.USD","BK4534","IE00BZ199S13.USD","LU2168564222.USD","LU2896262040.SGD","LU0957808578.USD","LU1934455863.HKD","LU1699723380.USD","LU0081259029.USD","LU2237957811.SGD","LU0203202063.USD","LU2242650005.HKD","LU1064131342.USD","LU2089283258.USD","IE0003U64NQ7.SGD","LU0158827781.USD","LU1400636574.HKD","LU1551013342.USD","LU0210536198.USD","LU2272731600.USD","LU2420271590.USD","IE00BQXX3D17.EUR","IE0034235295.USD","LU0215105999.USD","BK4567","LU1267930573.SGD","LU2458330243.SGD","LU1914381329.SGD","LU2746668461.USD","LU2746668974.SGD","LU2430703095.HKD","LU2552382058.USD","SGXZ31699556.SGD","LABU","LU0882574139.USD","NVDA","BK4614","LU1066051811.HKD","NVDG","LU1145028129.USD","LU0310800379.SGD","BK4585","SG9999018865.SGD","LU2506951792.HKD","IE00BJLML261.HKD","IE00BJJMRX11.SGD","IE00B775H168.HKD","LU2417539215.USD","LU1066051225.USD","BK4605","SG9999000418.SGD","NVDD","SG9999014914.USD","LU0345770308.USD","NVDQ","SG9999015358.SGD","LU1815333072.USD","LU0823421333.USD","LU2065170008.USD","LU1244550221.USD","LU0942090050.USD","IE00B4JS1V06.HKD","SG9999015952.SGD","LU2294711713.HKD","LU0820562030.AUD","LU0107464264.USD","LU0109392836.USD","LU0683600562.USD","LU2462157665.USD","LU0345770993.USD","LU2473716301.USD","SG9999015341.SGD","LU1496350502.SGD","LU0057025933.USD","IE0004445239.USD","LU0347712357.USD","IE0005OL40V9.USD","IE00B5949003.HKD","LU0979878070.USD","LU0234570918.USD","SG9999015945.SGD","ANV","IE000YTNTUN2.SGD","LU0053666078.USD","SG9999015978.USD","LU0070217475.USD","LU0820561909.HKD","LU2360106780.USD","LU0238689110.USD","LU0788109477.HKD","LU2271345857.HKD","IE00BFSS8Q28.SGD","LU2125154935.USD","LU2361044865.SGD","LU1400636657.SGD","LU1629891620.HKD","BK4592","IE00B4YYXB79.USD","LU2592432038.USD","LU0965508806.USD","LU1791710400.SGD","IE00B775SV38.USD","LU0823414478.USD","IE00B19Z8W00.USD","LU2750360997.AUD","SG9999014542.SGD","IE00BHPRN162.USD","IE00BJTD4V19.USD","LU2487616109.SGD","LU1974910355.USD","SGXZ23171101.USD","BK4579","LU0096364046.USD","IE00BK4W5M84.HKD","LU2065169927.USD","LU1815336760.USD","LU1242518857.USD","LU1989772923.USD","LU0957791311.USD","BK4550","HK0000306701.USD","SG9999014559.SGD","GB00BDT5M118.USD","LU0466842654.USD","LU2458330169.SGD","LU0289961442.SGD","LU0724617625.USD","LU0965509010.AUD","LU0345769631.USD","LU0868494708.USD","LU0265550946.USD","LU2211815571.USD","LU1934455194.USD","LU2326559502.SGD","LU0256863902.USD","LU1642822529.SGD","LU2750360641.GBP","LU2125909916.SGD","LU1791710582.SGD","LU1868837300.USD","IE00BD6J9T35.USD","LU2106854487.HKD","NVDX","LU2125154778.USD","IE00BJTD4N35.SGD","LU0072462426.USD","LU0061474960.USD","BK4533","LU1244550494.USD","LU2471134879.HKD","IE00BJJMRY28.SGD","LU0158827948.USD","LU0342679015.USD","LU1551013425.SGD","LU1280957306.USD","LU2213496289.HKD","LU0964807845.USD","LU2433249047.HKD","HK0000914660.USD","LU1037948541.HKD","LU0494093205.USD","LU1035775433.USD","LU1066053197.SGD","LU1267930490.SGD","BK4608","LU2491050154.USD","LU0511384066.AUD","LU1821325948.USD","LU1861127337.USD","NVII","LU0080751232.USD","IE00B19Z8X17.USD","NVDU","LU0965509283.SGD","IE00B1BXHZ80.USD","LU0444971666.USD","LU0640476718.USD","LU0011850046.USD","LU2471134952.CNY","LU1674673691.USD","SGXZ99366536.SGD","LU0077335932.USD","LU2168564065.EUR","SGXZ81514606.USD","LU2403377893.USD","LU2089284900.SGD","LU0198837287.USD","NVDS.UK","LU0316494557.USD","SG9999004303.SGD","LU1983260115.SGD","LU0069063385.USD","LU2054465674.USD","IE00B3SWFQ91.USD","LU2381873111.SGD","LU2125909759.SGD","LU1935042488.USD","LU2272731782.SGD","LU1633808545.USD","LU0170899867.USD","LU1803068979.SGD","LU2543165471.USD","SG9999002224.SGD","LU1153585028.USD","2NVD.UK","BK4612","LU0124676726.USD","LU2471134523.USD","LU0889565833.HKD","LU2430703178.SGD","LU1935043023.USD","IE00B7KXQ091.USD","LU0267386448.USD","LU0079474960.USD","LU0157215616.USD","LU1066051498.USD","LU2456880835.USD","LU2756315318.SGD","LU0289739343.SGD","IE00BDCRKT87.USD","LU0094547139.USD","LU1951198990.SGD","LU1084165304.USD","LU1814569148.SGD","LU0353189763.USD","LU1645745479.HKD","LU0210528500.USD","LU2168563687.JPY","LU2430703251.USD","LU2077746001.SGD","LU2242649171.HKD","LU2505996509.AUD","BK4503","LU2092937148.SGD","XBI","SG9999014575.USD","SG9999014567.USD","LU2552382132.HKD","LU0472753341.HKD","LU1923623000.USD","LU1992135399.USD","LU0689472784.USD","LU2191332357.HKD","HK0000320223.HKD","LU0056508442.USD","LU2290526834.HKD","BK4529","LU2087621335.USD","LU0345769128.USD","LU0234572021.USD","DIPS","LU1069344957.HKD","LU0289960550.SGD","LU1721428933.USD","LU1400636491.USD","LU1935042991.SGD","SG9999015986.USD","LU2357305700.SGD","LU0320765059.SGD","LU0708994859.HKD","IE00BFSS7M15.SGD","LU1935043536.SGD","LU2065171311.SGD","LU1116320737.USD","LU0127658192.USD","LU2860962120.EUR","LU2023250330.USD","LU2249611893.SGD","LU0348723411.USD","LU0823414551.USD","LU0345768153.USD","LU1429558221.USD","LU2491049909.HKD","LU0323591593.USD","LU1720051108.HKD","LU2237438978.USD","LU0276348264.USD","LU2087625088.SGD","IE0004091025.USD","NVDW","BK4543","LU0175139822.USD"],"gpt_icon":0},{"id":"2620384444","title":"Predict taps Mistral chief Cafagna to drive Digital Healthcare growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2620384444","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620384444?lang=en_us&edition=fundamental","pubTime":"2026-03-17 15:56","pubTimestamp":1773734204,"startTime":"0","endTime":"0","summary":"Predict S.P.A. Class B ( ($IT:PRE) ) just unveiled an announcement. Predict S.p.A. has appointed long‑standing executive Isabella Cafagna as direct...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/predict-taps-mistral-chief-cafagna-to-drive-digital-healthcare-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/predict-taps-mistral-chief-cafagna-to-drive-digital-healthcare-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0029874061.USD","VGT","XLV","BK4585","HCSG","XBI","BK4588","LU0128526141.USD","BK4581","LABU"],"gpt_icon":0},{"id":"2620446954","title":"Healthcare & Medical Investment Corp. Posts Modest Growth and Signals Flat Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2620446954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620446954?lang=en_us&edition=fundamental","pubTime":"2026-03-17 14:58","pubTimestamp":1773730730,"startTime":"0","endTime":"0","summary":"Healthcare & Medical Investment Corp ( ($JP:3455) ) has shared an announcement. Healthcare & Medical Investment Corp. reported modest growth for th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthcare-medical-investment-corp-posts-modest-growth-and-signals-flat-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthcare-medical-investment-corp-posts-modest-growth-and-signals-flat-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4581","XBI","BK4137","LU0029874061.USD","XLV","LU0128526141.USD","HCSG","BK4588","LABU"],"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":8,"totalSize":432,"code":"91000000","status":"200"}]}}